ECM Technologies
A Texas A&M University-based start-up that utilizes bacterial-derived proteins as a platform for designing collagens for biomedical needs.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$280k | Seed | ||
| Total Funding | 000k | ||
Related Content
Designer Collagens operates at the intersection of biotechnology and medical innovation, specializing in the development of collagen-based products for both human and veterinary use. The company focuses on extracellular matrix (ECM) biosurgery technologies to create advanced solutions for wound healing, surgical procedures, and regenerative medicine. Its clientele includes medical professionals, veterinary practitioners, and research institutions. Operating in the biotech and healthcare markets, Designer Collagens employs a business model centered around research and development, product sales, and strategic partnerships. Revenue is generated through the commercialization of patented technologies and products, as well as through collaborations with academic and medical institutions.
Keywords: collagen, ECM biosurgery, wound healing, regenerative medicine, medical devices, veterinary applications, biotechnology, surgical solutions, patented technologies, healthcare innovation.